PL3775909T3 - Środki i sposoby do profilowania glikozylacji białka - Google Patents
Środki i sposoby do profilowania glikozylacji białkaInfo
- Publication number
- PL3775909T3 PL3775909T3 PL19718572.1T PL19718572T PL3775909T3 PL 3775909 T3 PL3775909 T3 PL 3775909T3 PL 19718572 T PL19718572 T PL 19718572T PL 3775909 T3 PL3775909 T3 PL 3775909T3
- Authority
- PL
- Poland
- Prior art keywords
- glycoprofiling
- protein
- methods
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57434—Specifically defined cancers of prostate
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/415—Assays involving biological materials from specific organisms or of a specific nature from plants
- G01N2333/42—Lectins, e.g. concanavalin, phytohaemagglutinin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4724—Lectins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/02—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates involving antibodies to sugar part of glycoproteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/70—Mechanisms involved in disease identification
- G01N2800/7095—Inflammation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18163899 | 2018-03-26 | ||
| PCT/EP2019/057386 WO2019185515A1 (en) | 2018-03-26 | 2019-03-25 | Means and methods for glycoprofiling of a protein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3775909T3 true PL3775909T3 (pl) | 2023-09-18 |
Family
ID=61800357
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19718572.1T PL3775909T3 (pl) | 2018-03-26 | 2019-03-25 | Środki i sposoby do profilowania glikozylacji białka |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20210048437A1 (pl) |
| EP (2) | EP4253958A3 (pl) |
| JP (1) | JP2021519443A (pl) |
| KR (1) | KR20200138300A (pl) |
| AU (1) | AU2019246007A1 (pl) |
| CA (1) | CA3091733A1 (pl) |
| DK (1) | DK3775909T3 (pl) |
| ES (1) | ES2950740T3 (pl) |
| FI (1) | FI3775909T3 (pl) |
| HR (1) | HRP20230744T1 (pl) |
| HU (1) | HUE062414T2 (pl) |
| IL (1) | IL277194A (pl) |
| LT (1) | LT3775909T (pl) |
| PL (1) | PL3775909T3 (pl) |
| PT (1) | PT3775909T (pl) |
| RS (1) | RS64431B1 (pl) |
| SI (1) | SI3775909T1 (pl) |
| WO (1) | WO2019185515A1 (pl) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111208304B (zh) * | 2020-01-20 | 2023-06-16 | 中国医学科学院北京协和医院 | 肿瘤来源IgG在甲状旁腺癌诊断和预后中的用途 |
| CN113009131B (zh) * | 2021-02-10 | 2022-08-23 | 中国医学科学院北京协和医院 | 一种用于诊断原发性干燥综合征的生物标志物及其用途 |
| CN113009130B (zh) * | 2021-02-10 | 2022-08-23 | 中国医学科学院北京协和医院 | 一种用于诊断原发性干燥综合征的生物标志物及其用途 |
| WO2022186317A1 (ja) * | 2021-03-03 | 2022-09-09 | 株式会社先端生命科学研究所 | がん検出方法、がん検査方法、及びこれらに用いるキット |
| CN117881962A (zh) | 2021-08-06 | 2024-04-12 | Glycanostics 公司 | 用于蛋白糖谱表征的标准品 |
| CN113702637B (zh) * | 2021-08-09 | 2023-04-07 | 西北大学 | 乳腺癌新辅助化疗疗效预测的凝集素测试载体和试剂盒以及预测模型 |
| CN113721029B (zh) * | 2021-08-25 | 2023-06-06 | 西北大学 | 特定凝集素组合鉴别肝硬化、肝癌的测试工具及系统 |
| AU2022335718A1 (en) | 2021-08-26 | 2024-03-28 | Glycanostics S.R.O | Glycoprotein biomarkers for diagnosing cancer |
| AU2022346688A1 (en) | 2021-09-14 | 2024-04-04 | Glycanostics S.R.O | Use of lectins to determine mammaglobin-a glycoforms in breast cancer |
| WO2023198337A1 (en) | 2022-04-12 | 2023-10-19 | Glycanostics S.R.O. | Means and methods for high-throughput glycoprofiling of proteins |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816A (en) | 1846-10-17 | Bell machinery for hotels | ||
| US4676A (en) | 1846-07-31 | roller | ||
| US567A (en) | 1838-01-09 | Machine for r-uibbii | ||
| US980A (en) | 1838-10-13 | Improvement in the mode of hardening or chilling the hubs of car and other wheels | ||
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| JPS6147500A (ja) | 1984-08-15 | 1986-03-07 | Res Dev Corp Of Japan | キメラモノクロ−ナル抗体及びその製造法 |
| EP0173494A3 (en) | 1984-08-27 | 1987-11-25 | The Board Of Trustees Of The Leland Stanford Junior University | Chimeric receptors by dna splicing and expression |
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| EP0307434B2 (en) | 1987-03-18 | 1998-07-29 | Scotgen Biopharmaceuticals, Inc. | Altered antibodies |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| DE768377T1 (de) | 1988-09-02 | 1998-01-02 | Dyax Corp | Herstellung und Auswahl von Rekombinantproteinen mit verschiedenen Bindestellen |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5859205A (en) | 1989-12-21 | 1999-01-12 | Celltech Limited | Humanised antibodies |
| US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| DK0585287T3 (da) | 1990-07-10 | 2000-04-17 | Cambridge Antibody Tech | Fremgangsmåde til fremstilling af specifikke bindingsparelementer |
| GB9021679D0 (en) | 1990-10-05 | 1990-11-21 | Gorman Scott David | Antibody preparation |
| ES2113940T3 (es) | 1990-12-03 | 1998-05-16 | Genentech Inc | Metodo de enriquecimiento para variantes de proteinas con propiedades de union alteradas. |
| DE69233697T2 (de) | 1991-03-01 | 2008-01-24 | Dyax Corp., Cambridge | Verfahren zur Entwicklung von bindenden Mikroproteinen |
| DE69233750D1 (de) | 1991-04-10 | 2009-01-02 | Scripps Research Inst | Bibliotheken heterodimerer Rezeptoren mittels Phagemiden |
| ES2206447T3 (es) | 1991-06-14 | 2004-05-16 | Genentech, Inc. | Anticuerpo humanizado para heregulina. |
| DE4122599C2 (de) | 1991-07-08 | 1993-11-11 | Deutsches Krebsforsch | Phagemid zum Screenen von Antikörpern |
| ES2304786T3 (es) | 1995-04-27 | 2008-10-16 | Amgen Fremont Inc. | Anticuerpos anti-il-8 humanos, derivados a partir de xenoratones inmunizados. |
| EP0823941A4 (en) | 1995-04-28 | 2001-09-19 | Abgenix Inc | HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENO MOUSES |
| EP0859841B1 (en) | 1995-08-18 | 2002-06-19 | MorphoSys AG | Protein/(poly)peptide libraries |
| DK1500329T3 (da) | 1996-12-03 | 2012-07-09 | Amgen Fremont Inc | Humane antistoffer, der specifikt binder TNF-alfa |
| EP1724282B1 (en) | 1997-05-21 | 2013-05-15 | Merck Patent GmbH | Method for the production of non-immunogenic proteins |
| AU776910B2 (en) | 1998-12-08 | 2004-09-23 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Modifying protein immunogenicity |
| US7838634B2 (en) * | 2005-04-15 | 2010-11-23 | Van Andel Research Institute | Methods for measuring glycan levels of proteins |
| JP4711190B2 (ja) * | 2006-07-28 | 2011-06-29 | 国立大学法人 東京大学 | グリコシル化異常症の検査方法 |
| US9169327B2 (en) | 2008-03-12 | 2015-10-27 | Rowan University | Targeting of podoplanin with lectin for use in the prevention and treatment of cancer |
| US20110129849A1 (en) * | 2008-07-25 | 2011-06-02 | The Johns Hopkins University | Detection of prostate cancer using psa glycosylation patterns |
| JP2010091308A (ja) * | 2008-10-04 | 2010-04-22 | Sapporo Medical Univ | レクチン吸収法による前立腺がんの診断方法及び判定キット |
-
2019
- 2019-03-25 HR HRP20230744TT patent/HRP20230744T1/hr unknown
- 2019-03-25 PL PL19718572.1T patent/PL3775909T3/pl unknown
- 2019-03-25 HU HUE19718572A patent/HUE062414T2/hu unknown
- 2019-03-25 KR KR1020207030659A patent/KR20200138300A/ko not_active Application Discontinuation
- 2019-03-25 CA CA3091733A patent/CA3091733A1/en active Pending
- 2019-03-25 WO PCT/EP2019/057386 patent/WO2019185515A1/en unknown
- 2019-03-25 RS RS20230533A patent/RS64431B1/sr unknown
- 2019-03-25 ES ES19718572T patent/ES2950740T3/es active Active
- 2019-03-25 DK DK19718572.1T patent/DK3775909T3/da active
- 2019-03-25 EP EP23172000.4A patent/EP4253958A3/en active Pending
- 2019-03-25 LT LTEPPCT/EP2019/057386T patent/LT3775909T/lt unknown
- 2019-03-25 SI SI201930572T patent/SI3775909T1/sl unknown
- 2019-03-25 JP JP2021501084A patent/JP2021519443A/ja active Pending
- 2019-03-25 PT PT197185721T patent/PT3775909T/pt unknown
- 2019-03-25 EP EP19718572.1A patent/EP3775909B1/en active Active
- 2019-03-25 AU AU2019246007A patent/AU2019246007A1/en active Pending
- 2019-03-25 FI FIEP19718572.1T patent/FI3775909T3/fi active
- 2019-03-25 US US17/041,816 patent/US20210048437A1/en active Pending
-
2020
- 2020-09-07 IL IL277194A patent/IL277194A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| LT3775909T (lt) | 2023-08-10 |
| AU2019246007A1 (en) | 2020-09-10 |
| WO2019185515A1 (en) | 2019-10-03 |
| DK3775909T3 (da) | 2023-07-24 |
| PT3775909T (pt) | 2023-07-19 |
| SI3775909T1 (sl) | 2023-10-30 |
| EP3775909B1 (en) | 2023-05-10 |
| FI3775909T3 (fi) | 2023-08-01 |
| ES2950740T3 (es) | 2023-10-13 |
| EP4253958A3 (en) | 2023-12-06 |
| EP3775909A1 (en) | 2021-02-17 |
| EP4253958A2 (en) | 2023-10-04 |
| JP2021519443A (ja) | 2021-08-10 |
| IL277194A (en) | 2020-10-29 |
| CA3091733A1 (en) | 2019-10-03 |
| RS64431B1 (sr) | 2023-09-29 |
| KR20200138300A (ko) | 2020-12-09 |
| US20210048437A1 (en) | 2021-02-18 |
| HRP20230744T1 (hr) | 2023-10-27 |
| HUE062414T2 (hu) | 2023-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL277194A (en) | Means and methods for glycoprofiling of protein | |
| IL272218A (en) | ANTI-SIRP-ALPHA ANTIBODIES AND RELATED METHODS | |
| ZA202105676B (en) | Anti-trem2 antibodies and related methods | |
| IL267861A (en) | PD1-41BBL conjugate protein and methods of using it | |
| IL269074A (en) | Proteins that bind anti-TIGIT antigens and methods of using them | |
| IL267862A (en) | SIRPalpha-41BBL conjugate protein and methods of using it | |
| ZA202003695B (en) | Anti-neuropilin antigen-binding proteins and methods of use thereof | |
| IL287318A (en) | Materials and methods for the production of proteins | |
| SG11202012529VA (en) | Means and methods for increased protein expression by use of transcription factors | |
| IL277212A (en) | Anti-KLK5 antibodies and methods of use | |
| DK3737402T3 (en) | Modificeret protein | |
| IL276102A (en) | System and method for characterizing protein dimerization | |
| ZA201907063B (en) | Insecticidal proteins and methods for their use | |
| IL279355A (en) | Antigen binding protein against STEAP1 | |
| IL291284A (en) | Systems and methods for expression of proteins | |
| GB201703416D0 (en) | Method for protein expression | |
| ZA202210284B (en) | Anti-trem1 antibodies and related methods | |
| GB201818663D0 (en) | Peptides and method | |
| GB2575017B (en) | Alignment Arrangement and Method of Alignment | |
| GB201802757D0 (en) | Analyitical method and means | |
| GB201801920D0 (en) | Polypeptides and methods | |
| HK1218916A1 (zh) | 種固定化蛋白的方法 | |
| GB201704922D0 (en) | Methods of protein stapling |